Connection

MEHMET OKCU to Neuroblastoma

This is a "connection" page, showing publications MEHMET OKCU has written about Neuroblastoma.
Connection Strength

0.380
  1. Flow cytometry and fluorescence in situ hybridization to detect residual neuroblastoma cells in bone marrow. Pediatr Blood Cancer. 2005 Nov; 45(6):787-95.
    View in: PubMed
    Score: 0.175
  2. Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma. Oncogene. 2010 Sep 02; 29(35):4938-46.
    View in: PubMed
    Score: 0.060
  3. Aurora A is a negative prognostic factor and a new therapeutic target in human neuroblastoma. Mol Cancer Ther. 2009 Aug; 8(8):2461-9.
    View in: PubMed
    Score: 0.057
  4. Neuroblastoma-derived secretory protein messenger RNA levels correlate with high-risk neuroblastoma. J Pediatr Surg. 2007 Jan; 42(1):148-52.
    View in: PubMed
    Score: 0.047
  5. CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases. J Pediatr Surg. 2004 Oct; 39(10):1506-11.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.